Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2021 / Sep / Case of the Month (7)
Histology Histology Microbiology and Immunology

Case of the Month

09/13/2021 Quick Read (pre 2022) 1 min read

Share

A 57-year-old man living in Brazil had a history of chronic intestinal obstipation for over five years. Following serologic and radiologic workup, he underwent resection of the sigmoid and rectum. A 20x225.5 cm segment of markedly dilate large bowel was submitted for histopathological evaluation.

Which of the following infectious agents is the most likely cause of these pathologic changes?

a. Hymenolepis nana
b. Schistosoma mansoni
c. Schistosoma haematobium
d. Strongyloides stercoralis
e. Trypanosoma cruzi

Click here to register your guess.

Do you have an interesting case that you would like us to feature? Email it to edit@thepathologist.com.

Answer to September's Case of the Month.

A. Malignant PEComa

Histologic sections demonstrate a mesenchymal neoplasm comprised of polygonal perivascular epithelioid cells with granular, eosinophilic-to-clear cytoplasm and large vesicular nuclei with macro-nucleoli. Background showed areas of hemorrhage, focal spindle cell morphology, rare cells with adipocyte morphology, many multinucleated giant cells with pleomorphic nuclei, scattered highly pleomorphic cells, and a focal area of coagulative necrosis. No mitotic figures were identified.  The epithelioid cell component was approximately 90 percent of the tumor volume. Immunostains showed that the epithelioid cells were positive for MART-1 and HMB-45 and focally positive for actin. Desmin was positive in rare cells. The epithelioid cells were negative for pankeratin, AE1/AE3, Cam 5.2, cytokeratin 7, epithelial membrane antigen (EMA), CD10, RCC, CD117, S-100, PAX8, GATA3, and calretinin. Multinucleated cells were highlighted by CD68 and CD163 stains. FISH was negative for TFE3 translocation.

The PEComa family includes angiomyolipoma (AML), lymphangiomyomatosis of the lung, the clear cell “sugar” tumors of lung and other organs, and a rare group of morphologically and immunophenotypically similar tumors occurring throughout the body in soft tissues, viscera, and bones. Most PEComas are benign and predominantly affect women. Folpe et al. described the criteria for classifying PEComas into benign, uncertain malignant potential (size >5 cm or nuclear pleomorphism/multinucleated giant cells only) and malignant (two or more of: size >5 cm, infiltrative, high nuclear grade and cellularity, mitotic rate ≥1/50 HPF, necrosis or vascular invasion).

Renal AMLs account for 1 percent of renal tumors and are commonly associated with tuberous sclerosis complex. Apart from the classic variant, other rare morphologic variants include epithelioid, atypical, oncocytic, clear cell, and cystic. This case demonstrates a morphologic and immunohistochemical neoplasm with melanocytic and myogenic phenotype and >2 criteria for malignant PEComa, supporting a final diagnosis of malignant PEComa.

Submitted by Swati Satturwar, Genitourinary Pathology Fellow, and Rajiv Dhir, Executive Vice-Chair, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Further Reading

  1. G Martignoni et al., “Mesenchymal tumors occurring mainly in adults,” WHO Classification of the Urinary System and Male Genital Organs, 4th Edition, 62. IARC: 2016.
  2. LA Doyle et al., “PEComa,” WHO Classification of Soft Tissue and Bone Tumors, 5th Edition, 312. IARC: 2019.
  3. AL Folpe, DJ Kwiatkowski, Hum Pathol, 41, 1 (2009). PMID: 19604538.
  4. O Mete, TH van der Kwast, Arch Pathol Lab Med, 135, 665 (2011). PMID: 21526965.
  5. Y Yang et al,. J Int Med Res, 48 (2020). PMID: 33070694.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Your Newest Colleague?
Histology
Your Newest Colleague?

January 6, 2022

1 min read

The need for AI-based end-to-end biomarkers in oncology

Biospecimen Access For Biotechs
Histology
Biospecimen Access For Biotechs

February 14, 2022

1 min read

Quality, provenance, and “taking pot luck”

Case of the Month
Histology
Case of the Month

February 21, 2022

1 min read

The Art of the Laboratory
Histology
The Art of the Laboratory

March 25, 2022

1 min read

For the seventh time, we asked you to share the images you think capture the most beautiful, educational, or amusing aspects of pathology – and you delivered. Welcome to our gallery tour of the most visually striking discipline in medicine!

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.